Cargando…

Carotenoids in Cancer Apoptosis—The Road from Bench to Bedside and Back

An incidence and mortality of cancer are rapidly growing worldwide, especially due to heterogeneous character of the disease that is associated with irreversible impairment of cellular homeostasis and function. Targeting apoptosis, one of cancer hallmarks, represents a potent cancer treatment strate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koklesova, Lenka, Liskova, Alena, Samec, Marek, Buhrmann, Constanze, Samuel, Samson Mathews, Varghese, Elizabeth, Ashrafizadeh, Milad, Najafi, Masoud, Shakibaei, Mehdi, Büsselberg, Dietrich, Giordano, Frank A., Golubnitschaja, Olga, Kubatka, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563597/ https://www.ncbi.nlm.nih.gov/pubmed/32859058 http://dx.doi.org/10.3390/cancers12092425

Ejemplares similares

Carotenoids in Cancer Metastasis—Status Quo and Outlook
por: Koklesova, Lenka, et al.
Publicado: (2020)

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
por: Samuel, Samson Mathews, et al.
Publicado: (2020)

Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism
por: Samec, Marek, et al.
Publicado: (2020)

Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person
por: Koklesova, Lenka, et al.
Publicado: (2021)

Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
por: Liskova, Alena, et al.
Publicado: (2021)

Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management
por: Liskova, Alena, et al.
Publicado: (2020)

Flavonoids in Cancer Metastasis
por: Liskova, Alena, et al.
Publicado: (2020)

Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
por: Varghese, Elizabeth, et al.
Publicado: (2020)

Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects
por: Samec, Marek, et al.
Publicado: (2021)

Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
por: Samec, Marek, et al.
Publicado: (2021)

Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
por: Crigna, Adriana Torres, et al.
Publicado: (2020)

Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine
por: Koklesova, Lenka, et al.
Publicado: (2021)

Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression
por: Varghese, Elizabeth, et al.
Publicado: (2020)

Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
por: Varghese, Elizabeth, et al.
Publicado: (2021)

Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
por: Brockmueller, Aranka, et al.
Publicado: (2021)

Targeting NF-κB Signaling by Calebin A, a Compound of Turmeric, in Multicellular Tumor Microenvironment: Potential Role of Apoptosis Induction in CRC Cells
por: Buhrmann, Constanze, et al.
Publicado: (2020)

Fluctuations of Histone Chemical Modifications in Breast, Prostate, and Colorectal Cancer: An Implication of Phytochemicals as Defenders of Chromatin Equilibrium
por: Samec, Marek, et al.
Publicado: (2019)

Flavonoids in Cancer and Apoptosis
por: Abotaleb, Mariam, et al.
Publicado: (2018)

Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2022)

Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine
por: Kubatka, Peter, et al.
Publicado: (2022)

Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects—the evidence-based 3PM proposition to mitigate individual risks
por: Liskova, Alena, et al.
Publicado: (2021)

Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways
por: Kubatka, Peter, et al.
Publicado: (2021)

Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells
por: Mazurakova, Alena, et al.
Publicado: (2023)

Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles
por: Liskova, Alena, et al.
Publicado: (2021)

Flavonoids against the SARS-CoV-2 induced inflammatory storm
por: Liskova, Alena, et al.
Publicado: (2021)

Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care
por: Mazurakova, Alena, et al.
Publicado: (2022)

The Juggernaut of Adaptive Metabolism in Cancers: Implications and Therapeutic Targets
por: Samuel, Samson Mathews, et al.
Publicado: (2022)

Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management—Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2023)

Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
por: Zhai, Kevin, et al.
Publicado: (2021)

Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
por: Abu Samaan, Tala M., et al.
Publicado: (2019)

Anticancer Potential of Lichens’ Secondary Metabolites
por: Solárová, Zuzana, et al.
Publicado: (2020)

Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention
por: Koklesova, Lenka, et al.
Publicado: (2021)

Dietary Phytochemicals Targeting Cancer Stem Cells
por: Liskova, Alena, et al.
Publicado: (2019)

Multitargeting Effects of Calebin A on Malignancy of CRC Cells in Multicellular Tumor Microenvironment
por: Buhrmann, Constanze, et al.
Publicado: (2021)

Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection
por: Varghese, Elizabeth, et al.
Publicado: (2019)

Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology
por: Zubor, Pavol, et al.
Publicado: (2020)

Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine
por: Koklesova, Lenka, et al.
Publicado: (2020)

Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare
por: Zubor, Pavol, et al.
Publicado: (2020)

Tirzepatide—Friend or Foe in Diabetic Cancer Patients?
por: Samuel, Samson Mathews, et al.
Publicado: (2022)

miRNA Expression Profiles in Luminal A Breast Cancer—Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment
por: Kudela, Erik, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qsl2j7oed1db68s7ln6uq29t2d